Kidney Transplant Access Lags for Patients With Intellectual Disabilities
A Medicare analysis finds that people with end-stage kidney disease and intellectual or developmental disabilities are evaluated for and receive kidney transplants far less often than others, despite legal protections.
An analysis of Medicare data finds that people with end-stage kidney disease who also have intellectual or developmental disabilities are significantly less likely to be evaluated for a kidney transplant or to receive one. The findings, reported by MedPage Today, indicate that this disparity persists despite anti-discrimination laws that should protect these patients.
The gap appears at the evaluation stage, where fewer patients with IDD are considered for transplantation, and continues through to the transplant itself. The report does not specify the exact reasons for the disparity, but it highlights that the shortfall is present across the care pathway.
The analysis draws on Medicare records, offering a broad view of how the transplant pathway differs for this group. It adds to evidence that legal protections alone have not ensured equal access to kidney transplantation for people with intellectual and developmental disabilities.
Sources · 2
More in Medicine & Biotech
Rare Pregnancy Infections Linked to Autism and Intellectual Disability
A Karolinska Institutet study in JAMA Pediatrics finds that rare fetal infections are associated with higher risks of autism and intellectual disability.
Brain may be two fused organs, Stanford study suggests
New research indicates the human brain develops from two distinct cellular systems, hinting that evolution fused two ancient nervous systems.
Hidden Gut Defect in Remission May Explain IBD Relapses
A lingering molecular warning sign in gut tissue may explain why inflammatory bowel disease keeps returning.
AI turns unstructured clinical data into research-ready variables
A new analysis highlights how AI can help healthcare organizations convert fragmented, unstructured data into structured variables, addressing a major bottleneck in clinical research.